ctrl K

AI Score

Unlock

TransCode Therapeutics In... (RNAZ)

AI Score

Unlock

2.00

-0.52 (-20.63%)

At close: Feb 28, 2025, 3:59 PM

1.99

-0.46%

After-hours: Feb 28, 2025, 05:54 PM EST

TransCode Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	516.75K	98.61K	42.47K	n/a	n/a	n/a
Gross Profit	-516.75K	-98.61K	-42.47K	n/a	n/a	n/a
Operating Income	-19.42M	-18.67M	-6.15M	-726.6K	-456.87K	-384K
Interest Income	n/a	20.41K	664.00	136.00	34.00	68.92K
Pretax Income	-18.55M	-17.56M	-6.84M	-2.34M	-607.21K	-453.44K
Net Income	-18.55M	-35.13M	-6.94M	-2.74M	-764.14K	-453.44K
Selling & General & Admin	6.64M	8.43M	3.4M	442.14K	230.56K	301.46K
Research & Development	12.26M	10.23M	2.75M	284.46K	226.31K	82.53K
Other Expenses	n/a	-1.08M	-278.33K	n/a	n/a	n/a
Operating Expenses	19.42M	17.59M	5.87M	726.6K	456.87K	384.52K
Interest Expense	50.61K	17.56M	95.07K	394.57K	156.97K	n/a
Selling & Marketing Expenses	-7.15B	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	19.42M	17.59M	5.87M	726.6K	456.87K	384.52K
Income Tax	n/a	17.56M	95.07K	394.44K	156.93K	-69.44K
Shares Outstanding (Basic)	179K	16K	10.53K	7.98K	6.41K	6.41K
Shares Outstanding (Diluted)	179.01K	16.22K	10.53K	7.98K	6.41K	6.41K
EPS (Basic)	-103.61	-2.2K	-658.8	-343.19	-119.27	-70.77
EPS (Diluted)	-103.61	-2.17K	-658.8	-343.19	-119.27	-70.77
EBITDA	-17.97M	-17.47M	-6.11M	n/a	n/a	-69.44K
Depreciation & Amortization	516.75K	98.61K	42.47K	726.6K	456.87K	384K